Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Impact of antibiotic use on survival in patients with advanced cancers treated on immune checkpoint inhibitor phase I clinical trials.

Literature DB >> 30307530

Impact of antibiotic use on survival in patients with advanced cancers treated on immune checkpoint inhibitor phase I clinical trials.

S Sen¹, R Carmagnani Pestana², K Hess³, G M Viola⁴, V Subbiah⁵.

Abstract

Entities: Disease Species

Mesh：

Substances：

Year: 2018 PMID： 30307530 PMCID： PMC6311953 DOI： 10.1093/annonc/mdy453

Source DB: PubMed Journal: Ann Oncol ISSN： 0923-7534 Impact factor: 32.976

× No keyword cloud information.

6 in total

Review 1. Antibiotics and the gut microbiota.

Authors: Sheetal R Modi; James J Collins; David A Relman
Journal: J Clin Invest Date: 2014-10-01 Impact factor: 14.808

2. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.

Authors: Bertrand Routy; Emmanuelle Le Chatelier; Lisa Derosa; Connie P M Duong; Maryam Tidjani Alou; Romain Daillère; Aurélie Fluckiger; Meriem Messaoudene; Conrad Rauber; Maria P Roberti; Marine Fidelle; Caroline Flament; Vichnou Poirier-Colame; Paule Opolon; Christophe Klein; Kristina Iribarren; Laura Mondragón; Nicolas Jacquelot; Bo Qu; Gladys Ferrere; Céline Clémenson; Laura Mezquita; Jordi Remon Masip; Charles Naltet; Solenn Brosseau; Coureche Kaderbhai; Corentin Richard; Hira Rizvi; Florence Levenez; Nathalie Galleron; Benoit Quinquis; Nicolas Pons; Bernhard Ryffel; Véronique Minard-Colin; Patrick Gonin; Jean-Charles Soria; Eric Deutsch; Yohann Loriot; François Ghiringhelli; Gérard Zalcman; François Goldwasser; Bernard Escudier; Matthew D Hellmann; Alexander Eggermont; Didier Raoult; Laurence Albiges; Guido Kroemer; Laurence Zitvogel
Journal: Science Date: 2017-11-02 Impact factor: 47.728

3. Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer.

Authors: L Derosa; M D Hellmann; M Spaziano; D Halpenny; M Fidelle; H Rizvi; N Long; A J Plodkowski; K C Arbour; J E Chaft; J A Rouche; L Zitvogel; G Zalcman; L Albiges; B Escudier; B Routy
Journal: Ann Oncol Date: 2018-06-01 Impact factor: 32.976

4. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota.

Authors: Marie Vétizou; Jonathan M Pitt; Romain Daillère; Patricia Lepage; Nadine Waldschmitt; Caroline Flament; Sylvie Rusakiewicz; Bertrand Routy; Maria P Roberti; Connie P M Duong; Vichnou Poirier-Colame; Antoine Roux; Sonia Becharef; Silvia Formenti; Encouse Golden; Sascha Cording; Gerard Eberl; Andreas Schlitzer; Florent Ginhoux; Sridhar Mani; Takahiro Yamazaki; Nicolas Jacquelot; David P Enot; Marion Bérard; Jérôme Nigou; Paule Opolon; Alexander Eggermont; Paul-Louis Woerther; Elisabeth Chachaty; Nathalie Chaput; Caroline Robert; Christina Mateus; Guido Kroemer; Didier Raoult; Ivo Gomperts Boneca; Franck Carbonnel; Mathias Chamaillard; Laurence Zitvogel
Journal: Science Date: 2015-11-05 Impact factor: 47.728

5. Development of a prognostic scoring system for patients with advanced cancer enrolled in immune checkpoint inhibitor phase 1 clinical trials.

Authors: Shiraj Sen; Kenneth Hess; David S Hong; Aung Naing; Sarina Piha-Paul; Filip Janku; Siqing Fu; Ishwaria M Subbiah; Holly Liu; Rahil Khanji; Le Huang; Shhyam Moorthy; Daniel D Karp; Apostolia Tsimberidou; Funda Meric-Bernstam; Vivek Subbiah
Journal: Br J Cancer Date: 2018-02-20 Impact factor: 7.640

Review 6. Current understanding of the human microbiome.

Authors: Jack A Gilbert; Martin J Blaser; J Gregory Caporaso; Janet K Jansson; Susan V Lynch; Rob Knight
Journal: Nat Med Date: 2018-04-10 Impact factor: 53.440

6 in total

16 in total

1. Cumulative Antibiotic Use Significantly Decreases Efficacy of Checkpoint Inhibitors in Patients with Advanced Cancer.

Authors: Nadina Tinsley; Cong Zhou; Grace Tan; Samuel Rack; Paul Lorigan; Fiona Blackhall; Matthew Krebs; Louise Carter; Fiona Thistlethwaite; Donna Graham; Natalie Cook
Journal: Oncologist Date: 2019-07-10

2. Gut microbiome, antibiotic use, and immunotherapy responsiveness in cancer.

Authors: Jarred P Reed; Suzanne Devkota; Robert A Figlin
Journal: Ann Transl Med Date: 2019-12

Review 3. Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome.

Authors: Ziying Zhang; Haosheng Tang; Peng Chen; Hui Xie; Yongguang Tao
Journal: Signal Transduct Target Ther Date: 2019-10-12

4. Antibiotic use and the efficacy of immune checkpoint inhibitors in cancer patients: a pooled analysis of 2740 cancer patients.

Authors: Xuan-Zhang Huang; Peng Gao; Yong-Xi Song; Yan Xu; Jing-Xu Sun; Xiao-Wan Chen; Jun-Hua Zhao; Zhen-Ning Wang
Journal: Oncoimmunology Date: 2019-09-23 Impact factor: 8.110

5. Comparative analysis of antibiotic exposure association with clinical outcomes of chemotherapy versus immunotherapy across three tumour types.

Authors: Amit A Kulkarni; Maryam Ebadi; Shijia Zhang; Mohamad A Meybodi; Alaa M Ali; Todd DeFor; Ryan Shanley; Daniel Weisdorf; Charles Ryan; Sumithira Vasu; Armin Rashidi; Manish Ramesh Patel
Journal: ESMO Open Date: 2020-09